Progress in prevention and treatment of cytomegalovirus infection in patients with allogeneic hematopoietic stem cell transplantation
10.3760/cma.j.cn112150-20240503-00358
- VernacularTitle:异基因造血干细胞移植患者巨细胞病毒感染预防与治疗的研究进展
- Author:
Shuqin ZHONG
1
;
Nainong LI
;
Meihua WANG
Author Information
1. 福建医科大学附属协和医院检验科，福州 350001
- Keywords:
Allogeneic hematopoietic stem cell transplantation;
Cytomegalovirus;
Infection;
Prevention;
Adoptive immune cell therapy
- From:
Chinese Journal of Preventive Medicine
2024;58(11):1763-1770
- CountryChina
- Language:Chinese
-
Abstract:
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains an effective treatment for hematological malignancies. Cytomegalovirus (CMV) infection is one of the common Infection complications after hematopoietic stem cell transplantation, and also the main cause of death of transplant recipients, which has a significant impact on the prognosis and survival of transplant recipients. It is particularly important to take timely and effective prevention and treatment for CMV infected transplant patients. This article discusses the latest prevention and treatment of CMV infection after transplantation,and reviews the recent progress in the prevention and drug treatment of CMV infection in allo-HSCT patients by searching the relevant literature through Pubmed.
